ARROWHEAD PHARMACEUTICALS, INC. (ARWR) insider trading

By person

14 insiders · 0 transactions

337×

Christopher Anzalone holds 337 times base salary in stock. $331.11M of shares against $981.05K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Anzalone last reported holding, valued at $87.30, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Christopher Richard Anzalone

Chief Executive Officer

—

3,792,739

$331.11M

+2.1%

Patrick O'Brien

COO

—

547,408

$47.79M

+17.9%

Kenneth Allen Myszkowski

Chief Financial Officer

—

455,433

$39.76M

+13.7%

James C Hamilton

Chief Medical Officer

—

226,958

$19.81M

+10.8%

Daniel Joseph Apel

Chief Financial Officer

—

162,905

$14.22M

+61.3%

Douglas B Given

Director

—

124,167

$10.84M

−4.3%

Michael S Perry

Director

—

111,459

$9.73M

−2.9%

Mauro Ferrari

Director

—

69,053

$6.03M

+13.6%

William D. Waddill

Director

—

56,563

$4.94M

+18.2%

Hongbo Lu

Director

—

52,012

$4.54M

+70.9%

Douglas S Ingram

Director

—

46,215

$4.03M

—

Victoria Vakiener

Director

—

35,723

$3.12M

+18.3%

Adeoye Y Olukotun

Director

—

31,600

$2.76M

+38.3%

Matthew Gregory Cohen

Director

—

11,882

$1.04M

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

ARROWHEAD PHARMACEUTICALS, INC.

What the insiders did No buying or selling

By person